Business · 20/11/2001
FDA Releases Draft Guidance on Clinical Trial Data Monitoring Committees
The Food and Drug Administration (FDA) has made available a draft document outlining the establishment and operation of data monitoring committees for clinical trials, aiming to enhance study monitoring and provide clarity for sponsors.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →